See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot3,994▼ 0.75%WTI103.27▲ 3.82%
← CDGP page
XStocksXray
Market X-Ray report · 23 October 2026

Chapel Down Group Plc (CDGP)

London Exchange · UK · prices in GBX · close of 23 Oct 2026

Key indicators

Last closeGBX 42.50
52-week range30.00 – 53.00
Return, 1 month / 3 months−12.4% / −4.5%
Return, 1 year / 3 years+9.0% / –
TrendAbove 200-day, below 50-day
RSI (14)25
Volatility (1 year)26.4%
Worst drawdown (1 year)-21.3%
Average daily value traded3.35M GBX
Dividend yield–

Market X-Ray price-based

69/ 100 · High confidence · ahead of 84% of stocks on this exchange
Trend71
Momentum68
Stability (higher is calmer)71
Liquidity64
Income–

Five-year price chart navy: price · brown: 200-day average

28.5942.1755.7569.3382.912023-122024-082025-052026-022026-10

About the company

Chapel Down Group is an English wine producer based in Kent, making sparkling wines, still wines, and also beer and cider. Its customers include retailers, pubs, restaurants and hotels across the United Kingdom, as well as visitors to its own vineyard and winery sites, where tours and tastings are offered. The company grows grapes on its own estates and also buys fruit from other English growers, and it sells its drinks under its own brand names.

On this site Chapel Down Group Plc appears as a stock on the London Exchange (UK), code CDGP, with prices in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Chapel Down Group Plc (CDGP) trades on the London Exchange in UK. It last closed at GBX 42.50 on 23 October 2026.

Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 617 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 9.0% and over the last three months it fell 4.5%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Chapel Down Group Plc (CDGP)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend71 · StrongTrading above its long-term averages and near its highs.
Above 200-day average5.1%
From 52-week high-15.0%
Momentum68 · FairTypical recent returns for this exchange.
3-month return-4.5%
6-month return34.9%
12-month return, skipping the last month24.4%
Stability (higher is calmer)71 · StrongCalmer than most: low volatility and shallow drawdowns.
Volatility, 1 year (lower is calmer)26.4%
Worst drawdown, 1 year (smaller is calmer)-21.3%
Liquidity64 · FairModerate trading activity.
Average daily value traded3.35M GBX
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.

Weak spots

No lens is weak against its exchange.

Returns

1 week−4.5%
1 month−12.4%
3 months−4.5%
6 months+34.9%
1 year+9.0%
3 years–
5 years–

Signals

50-day / 200-day average46.77 / 40.44
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.83

Technical summary

DailyBearish5 bullish · 0 neutral · 11 bearish
WeeklyNeutral4 bullish · 1 neutral · 5 bearish
MonthlyBullish3 bullish · 1 neutral · 2 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 25 Oct 2026